162 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 4 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MYH11Myosin, heavy chain 11, smooth muscleCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
MYH6Myosin, heavy chain 6, cardiac muscle, alphaCandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Tissue enriched
MYH7Myosin, heavy chain 7, cardiac muscle, betaCandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Group enriched
MYL2Myosin, light chain 2, regulatory, cardiac, slowCandidate cardiovascular disease genes
Cytoskeleton related proteins
Disease related genes
Predicted intracellular proteins
Group enriched
MYL3Myosin, light chain 3, alkali; ventricular, skeletal, slowCandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Group enriched
NGFNerve growth factor (beta polypeptide)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
NPPANatriuretic peptide ACandidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
NPPBNatriuretic peptide BCandidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
ORM1Orosomucoid 1Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
PAPPAPregnancy-associated plasma protein A, pappalysin 1Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted secreted proteins
Tissue enriched
PDGFAPlatelet-derived growth factor alpha polypeptideCancer-related genes
Candidate cardiovascular disease genes
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
PDGFBPlatelet-derived growth factor beta polypeptideCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PF4Platelet factor 4Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
PGAM1Phosphoglycerate mutase 1 (brain)Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Expressed in all
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLA2G1BPhospholipase A2, group IB (pancreas)Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
PLA2G7Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Mixed
PLATPlasminogen activator, tissueCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Mixed
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PON1Paraoxonase 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Transporters
Tissue enriched
PON2Paraoxonase 2Candidate cardiovascular disease genes
Enzymes
Predicted secreted proteins
Expressed in all
PON3Paraoxonase 3Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted secreted proteins
Tissue enriched
PROCProtein C (inactivator of coagulation factors Va and VIIIa)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PROCRProtein C receptor, endothelialCandidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted membrane proteins
Mixed
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PROZProtein Z, vitamin K-dependent plasma glycoproteinCandidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted secreted proteins
Group enriched
PRTN3Proteinase 3Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PYGBPhosphorylase, glycogen; brainCandidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Expressed in all
RENReninCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
RETNResistinCandidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
S100BS100 calcium binding protein BCancer-related genes
Candidate cardiovascular disease genes
Predicted intracellular proteins
Group enriched
SAA1Serum amyloid A1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Group enriched
SAA2Serum amyloid A2Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Group enriched
SELESelectin ECancer-related genes
Candidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
SELLSelectin LCancer-related genes
Candidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted membrane proteins
Tissue enhanced
SELPSelectin P (granule membrane protein 140kDa, antigen CD62)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
SELPLGSelectin P ligandCandidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted membrane proteins
Expressed in all
SERPINA1Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
SERPINA3Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
SERPINA5Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
SERPINC1Serpin peptidase inhibitor, clade C (antithrombin), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin peptidase inhibitor, clade D (heparin cofactor), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPINE1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
SERPINF2Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPING1Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
SHBGSex hormone-binding globulinCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
TFPITissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
TGFB1Transforming growth factor, beta 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
THBDThrombomodulinCandidate cardiovascular disease genes
CD markers
Disease related genes
Predicted membrane proteins
Expressed in all
THBS1Thrombospondin 1Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced

« prev | Page of 4 | next »